AÑO
2017
CATEGORÍA
Trabajo
OBJETIVOS
Salud y bienestar
PAL. CLAVE
RNA & DNA, Cancer Detection
PAÍS
Brasil
CRÉDITOS
Deborah Zanforlin, M.Sc. Co-founder, CEO, Jakub Chudik Co-founder, Chief Technology Officer and To Nhu Huynh, MPH Co-founder, Chief Operating Officer - ConquerX
LINK
http://conquerxlab.com/
ConquerX - OligoStat & Metachip
The future of precision medicine
ConquerX's OligoStat technology represents a game-changing approach on molecular profiling and analysis by leveraging a combination of a biosensor technology and high performance nanocomposite to detection of molecular targets fast and accurate.
The OligoStat is an optimized electrochemical biosensor capable of running analyses of molecular biomarkers such DNA sequences, ctDNA and microRNA panels with a single biological sample without the need for amplification or sequencing.
Right now the average wait time of 3 - 7h per analysis means it takes longer time to realize negative results, which means longer duration of trials. The Metachip workflow has three simple steps: draw blood, place the blood on the Metachip, and put the Metachip on a portable sensor-reader to get results in 15 minutes.